Many studies with the knocking down of HIF-1α and HIF-2α in cancer cells have proven the significant role of these factors in promoting malignant growth and tumor resistance to hypoxia, as well as chemo- and radiotherapy (reviewed in [15,16,17,18]). This evidence concerns the gene EPAS1 and cancer.